Outcome of transarterial chemoembolization in patients with inoperable hepatocellular carcinoma eligible for radiofrequency ablation

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 11, Issue 29

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

All Articles published online

Item

Count

PDF

222

HTML

2705

Figures (1-1)

219

Tables (1-4)

215

Sum=3361

Aug 7, 2005 (publication date) through Nov 4, 2024

Times Cited of This Article

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Liver Cancer

World J Gastroenterol. Aug 7, 2005; 11(29): 4465-4471
Published online Aug 7, 2005. doi: 10.3748/wjg.v11.i29.4465

Table 2 Causes of death in 74 patients after TACE treatment

TACE: transarterial chemoembolization.

Citation: Liem MS, Poon RT, Lo CM, Tso WK, Fan ST. Outcome of transarterial chemoembolization in patients with inoperable hepatocellular carcinoma eligible for radiofrequency ablation. World J Gastroenterol 2005; 11(29): 4465-4471
URL: https://www.wjgnet.com/1007-9327/full/v11/i29/4465.htm
DOI: https://dx.doi.org/10.3748/wjg.v11.i29.4465